{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:49:10Z","timestamp":1792288150134,"version":"4.4.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nrneurol.2015.77","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T07:10:15Z","timestamp":1432019415000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Spinal muscular atrophy\u2014recent therapeutic advances for an old challenge"],"prefix":"10.1038","volume":"11","author":[{"given":"Irene","family":"Faravelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Nizzardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"BFnrneurol201577_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archneur.1971.00490030102014","volume":"25","author":"G Werdnig","year":"1971","unstructured":"Werdnig, G. Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891. Arch. Neurol. 25, 276\u2013278 (1971).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201577_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/344540a0","volume":"344","author":"LM Brzustowicz","year":"1990","unstructured":"Brzustowicz, L. M.  et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2\u2013133. Nature 344, 540\u2013541 (1990).","journal-title":"Nature"},{"key":"BFnrneurol201577_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2014","unstructured":"Arnold, W. D., Kassar, D. & Kissel, J. T. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve 51, 157\u2013167 (2014).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201577_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0b013e3182267bd8","volume":"77","author":"BT Darras","year":"2011","unstructured":"Darras, B. T. Non-5q spinal muscular atrophies: the alphanumeric soup thickens. Neurology 77, 312\u2013314 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol201577_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/brain\/awu356","volume":"138","author":"AM Rossor","year":"2014","unstructured":"Rossor, A. M.  et al. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2. Brain 138, 293\u2013310 (2014).","journal-title":"Brain"},{"key":"BFnrneurol201577_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman, E. A.  et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur. J. Hum. Genet. 20, 27\u201332 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneurol201577_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ajmg.a.33474","volume":"152A","author":"TW Prior","year":"2010","unstructured":"Prior, T. W.  et al. Newborn and carrier screening for spinal muscular atrophy. Am. J. Med. Genet. A. 152A, 1608\u20131616 (2010).","journal-title":"Am. J. Med. Genet. A."},{"key":"BFnrneurol201577_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel, R. S.  et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology 83, 810\u2013817 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol201577_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat, T. L. & Davies, K. E. International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany). Neuromuscul. Disord. 2, 423\u2013428 (1992).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201577_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter, M., Schwarzer, V., Wirth, R., Wienker, T. F. & Wirth, B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet. 70, 358\u2013368 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201577_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1884910","volume":"24","author":"S Cho","year":"2010","unstructured":"Cho, S. & Dreyfuss, G. A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 24, 438\u2013442 (2010).","journal-title":"Genes Dev."},{"key":"BFnrneurol201577_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri, E., Bertini, E. & Iannaccone, S. T. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 11, 443\u2013452 (2012).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201577_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang, C. H.  et al. Consensus statement for standard of care in spinal muscular atrophy. J. Child. Neurol. 22, 1027\u20131049 (2007).","journal-title":"J. Child. Neurol."},{"key":"BFnrneurol201577_CR14","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","volume":"19","author":"M Shababi","year":"2010","unstructured":"Shababi, M.  et al. Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum. Mol. Genet. 19, 4059\u20134071 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmg.2008.057950","volume":"45","author":"S Rudnik-Sch\u00f6neborn","year":"2008","unstructured":"Rudnik-Sch\u00f6neborn, S.  et al. Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J. Med. Genet. 45, 635\u2013638 (2008).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol201577_CR16","first-page":"175","volume":"30","author":"A Palladino","year":"2011","unstructured":"Palladino, A.  et al. Cardiac involvement in patients with spinal muscular atrophies. Acta Myol. 30, 175\u2013178 (2011).","journal-title":"Acta Myol."},{"key":"BFnrneurol201577_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1177\/0883073807305670","volume":"22","author":"ST Iannaccone","year":"2007","unstructured":"Iannaccone, S. T. Modern management of spinal muscular atrophy. J. Child. Neurol. 22, 974\u2013978 (2007).","journal-title":"J. Child. Neurol."},{"key":"BFnrneurol201577_CR18","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.jpedsurg.2008.05.035","volume":"43","author":"ET Durkin","year":"2008","unstructured":"Durkin, E. T., Schroth, M. K., Helin, M. & Shaaban, A. F. Early laparoscopic fundoplication and gastrostomy in infants with spinal muscular atrophy type I. J. Pediatr. Surg. 43, 2031\u20132037 (2008).","journal-title":"J. Pediatr. Surg."},{"key":"BFnrneurol201577_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.pmr.2012.08.005","volume":"23","author":"NC Joyce","year":"2012","unstructured":"Joyce, N. C., Hache, L. P. & Clemens, P. R. Bone health and associated metabolic complications in neuromuscular diseases. Phys. Med. Rehabil. Clin. N. Am. 23, 773\u2013799 (2012).","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"BFnrneurol201577_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.sleep.2014.05.029","volume":"15","author":"E Verrillo","year":"2014","unstructured":"Verrillo, E.  et al. Sleep architecture in infants with spinal muscular atrophy type 1. Sleep Med. 15, 1246\u20131250 (2014).","journal-title":"Sleep Med."},{"key":"BFnrneurol201577_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","volume":"68","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann, P.  et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch. Neurol. 68, 779\u2013786 (2011).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201577_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.braindev.2014.08.007","volume":"37","author":"P Yuan","year":"2014","unstructured":"Yuan, P. & Jiang, L. Clinical characteristics of three subtypes of spinal muscular atrophy in children. Brain Dev. 37, 537\u2013541 (2014).","journal-title":"Brain Dev."},{"key":"BFnrneurol201577_CR23","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","volume":"255","author":"S Piepers","year":"2008","unstructured":"Piepers, S.  et al. A natural history study of late onset spinal muscular atrophy types 3b and 4. J. Neurol. 255, 1400\u20131404 (2008).","journal-title":"J. Neurol."},{"key":"BFnrneurol201577_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/GIM.0b013e318220d523","volume":"13","author":"TW Prior","year":"2011","unstructured":"Prior, T. W., Nagan, N., Sugarman, E. A., Batish, S. D. & Braastad, C. Technical standards and guidelines for spinal muscular atrophy testing. Genet. Med. 13, 686\u2013694 (2011).","journal-title":"Genet. Med."},{"issue":"6","key":"BFnrneurol201577_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ejhg.2012.62","volume":"20","author":"Sabine Rudnik\u2013Sch\u00f6neborn","year":"2012","unstructured":"Rudnik\u2013Sch\u00f6neborn, S.  et al. Clinical utility gene card for: proximal spinal muscular atrophy. Eur. J. Hum. Genet. 20, (2012).","journal-title":"European Journal of Human Genetics"},{"key":"BFnrneurol201577_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D'Amico","year":"2011","unstructured":"D'Amico, A., Mercuri, E., Tiziano, F. D. & Bertini, E. Spinal muscular atrophy. Orphanet J. Rare Dis. 6, 71 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneurol201577_CR27","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/ajmg.a.36543","volume":"164A","author":"Z Vilchis","year":"2014","unstructured":"Vilchis, Z.  et al. The high frequency of genetic diseases in hypotonic infants referred by neuropediatrics. Am. J. Med. Genet. A. 164A, 1702\u20131705 (2014).","journal-title":"Am. J. Med. Genet. A."},{"key":"BFnrneurol201577_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S.  et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"BFnrneurol201577_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00439-002-0828-x","volume":"111","author":"S Ogino","year":"2002","unstructured":"Ogino, S. & Wilson, R. B. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum. Genet. 111, 477\u2013500 (2002).","journal-title":"Hum. Genet."},{"key":"BFnrneurol201577_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.24316","volume":"77","author":"MA Scully","year":"2014","unstructured":"Scully, M. A., Farrell, P. M., Ciafaloni, E., Griggs, R. C. & Kwon, J. M. Cystic fibrosis newborn screening: a model for neuromuscular disease screening? Ann. Neurol. 77, 189\u2013197 (2014).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201577_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1172\/JCI74142","volume":"124","author":"KJ Swoboda","year":"2014","unstructured":"Swoboda, K. J. SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet? J. Clin. Invest. 124, 487\u2013490 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201577_CR32","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1002\/ana.23984","volume":"74","author":"SJ Kolb","year":"2013","unstructured":"Kolb, S. J. NeuroNEXT SMA biomarkers study. Ann. Neurol. 74, A8 (2013).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201577_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11940-014-0316-3","volume":"16","author":"D Castro","year":"2014","unstructured":"Castro, D. & Iannaccone, S. T. Spinal muscular atrophy: therapeutic strategies. Curr. Treat. Options Neurol. 16, 316 (2014).","journal-title":"Curr. Treat. Options Neurol."},{"key":"BFnrneurol201577_CR34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani, U. R.  et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177\u20131183 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR35","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307\u20136311 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201577_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett, B. G.  et al. Regulation of SMN protein stability. Mol. Cell. Biol. 29, 1107\u20131115 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneurol201577_CR37","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/mus.21350","volume":"40","author":"B Elsheikh","year":"2009","unstructured":"Elsheikh, B.  et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve 40, 652\u2013656 (2009).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201577_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ajmg.a.30251","volume":"130A","author":"TW Prior","year":"2004","unstructured":"Prior, T. W., Swoboda, K. J., Scott, H. D. & Hejmanowski, A. Q. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am. J. Med. Genet. A. 130A, 307\u2013310 (2004).","journal-title":"Am. J. Med. Genet. A."},{"key":"BFnrneurol201577_CR39","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank, B.  et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA 94, 9920\u20139925 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201577_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani, U. R.  et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333\u2013339 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le, T. T.  et al. SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14, 845\u2013857 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR42","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan, A. K.  et al. Early heart failure in the SMN\u03947 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum. Mol. Genet. 19, 3895\u20133905 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jneumeth.2006.11.002","volume":"161","author":"MER Butchbach","year":"2007","unstructured":"Butchbach, M. E. R., Edwards, J. D., Schussler, K. R. & Burghes, A. H. A novel method for oral delivery of drug compounds to the neonatal SMN\u03947 mouse model of spinal muscular atrophy. J. Neurosci. Methods 161, 285\u2013290 (2007).","journal-title":"J. Neurosci. Methods"},{"key":"BFnrneurol201577_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K. D.  et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 28, 271\u2013274 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol201577_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddq514","volume":"20","author":"E Dominguez","year":"2011","unstructured":"Dominguez, E.  et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum. Mol. Genet. 20, 681\u2013693 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR46","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/emmm.201202305","volume":"5","author":"JJ Cherry","year":"2013","unstructured":"Cherry, J. J.  et al. Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds. EMBO Mol. Med. 5, 1035\u20131050 (2013).","journal-title":"EMBO Mol. Med."},{"key":"BFnrneurol201577_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert, A. D.  et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277\u2013280 (2009).","journal-title":"Nature"},{"key":"BFnrneurol201577_CR48","doi-asserted-by":"publisher","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","volume":"7","author":"D Sareen","year":"2012","unstructured":"Sareen, D.  et al. Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS ONE 7, e39113 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201577_CR49","doi-asserted-by":"publisher","first-page":"165ra162","DOI":"10.1126\/scitranslmed.3004108","volume":"4","author":"S Corti","year":"2012","unstructured":"Corti, S.  et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci. Transl. Med. 4, 165ra162 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnrneurol201577_CR50","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2353\/ajpath.2007.070399","volume":"171","author":"J Vitte","year":"2007","unstructured":"Vitte, J.  et al. Refined characterization of the expression and stability of the SMN gene products. Am. J. Pathol. 171, 1269\u20131280 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol201577_CR51","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.1074\/jbc.M009162200","volume":"276","author":"J Wang","year":"2001","unstructured":"Wang, J. & Dreyfuss, G. A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN. J. Biol. Chem. 276, 9599\u20139605 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol201577_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","volume":"95","author":"L Pellizzoni","year":"1998","unstructured":"Pellizzoni, L., Kataoka, N., Charroux, B. & Dreyfuss, G. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95, 615\u2013624 (1998).","journal-title":"Cell"},{"key":"BFnrneurol201577_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmed.2006.01.005","volume":"12","author":"C Eggert","year":"2006","unstructured":"Eggert, C., Chari, A., Laggerbauer, B. & Fischer, U. Spinal muscular atrophy: the RNP connection. Trends Mol. Med. 12, 113\u2013121 (2006).","journal-title":"Trends Mol. Med."},{"key":"BFnrneurol201577_CR54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.embor.7400941","volume":"8","author":"L Pellizzoni","year":"2007","unstructured":"Pellizzoni, L. Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep. 8, 340\u2013345 (2007).","journal-title":"EMBO Rep."},{"key":"BFnrneurol201577_CR55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2008.09.020","volume":"135","author":"A Chari","year":"2008","unstructured":"Chari, A.  et al. An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs. Cell 135, 497\u2013509 (2008).","journal-title":"Cell"},{"key":"BFnrneurol201577_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1101\/sqb.2006.71.001","volume":"71","author":"DJ Battle","year":"2006","unstructured":"Battle, D. J.  et al. The SMN complex: an assembly machine for RNPs. Cold Spring Harb. Symp. Quant. Biol. 71, 313\u2013320 (2006).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BFnrneurol201577_CR57","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/0883073807305666","volume":"22","author":"SJ Kolb","year":"2007","unstructured":"Kolb, S. J., Battle, D. J. & Dreyfuss, G. Molecular functions of the SMN complex. J. Child. Neurol. 22, 990\u2013994 (2007).","journal-title":"J. Child. Neurol."},{"key":"BFnrneurol201577_CR58","doi-asserted-by":"publisher","first-page":"e921","DOI":"10.1371\/journal.pone.0000921","volume":"2","author":"F Gabanella","year":"2007","unstructured":"Gabanella, F.  et al. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS ONE 2, e921 (2007).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201577_CR59","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1093\/hmg\/ddi390","volume":"14","author":"F Gabanella","year":"2005","unstructured":"Gabanella, F., Carissimi, C., Usiello, A. & Pellizzoni, L. The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation. Hum. Mol. Genet. 14, 3629\u20133642 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR60","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes, A. H. & Beattie, C. E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597\u2013609 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol201577_CR61","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/hmg\/ddq508","volume":"20","author":"N Boulisfane","year":"2011","unstructured":"Boulisfane, N.  et al. Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient. Hum. Mol. Genet. 20, 641\u2013648 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR62","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1074962","volume":"298","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni, L., Yong, J. & Dreyfuss, G. Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775\u20131779 (2002).","journal-title":"Science"},{"key":"BFnrneurol201577_CR63","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","volume":"133","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z.  et al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585\u2013600 (2008).","journal-title":"Cell"},{"key":"BFnrneurol201577_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","volume":"32","author":"DK Li","year":"2014","unstructured":"Li, D. K., Tisdale, S., Lotti, F. & Pellizzoni, L. SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin. Cell Dev. Biol. 32, 22\u201329 (2014).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnrneurol201577_CR65","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI72017","volume":"124","author":"S Kariya","year":"2014","unstructured":"Kariya, S.  et al. Requirement of enhanced survival motoneuron protein imposed during neuromuscular junction maturation. J. Clin. Invest. 124, 785\u2013800 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201577_CR66","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea, G. E.  et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320, 524\u2013527 (2008).","journal-title":"Science"},{"key":"BFnrneurol201577_CR67","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.200303168","volume":"162","author":"ML McWhorter","year":"2003","unstructured":"McWhorter, M. L., Monani, U. R., Burghes, A. H. & Beattie, C. E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919\u2013931 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnrneurol201577_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/hmg\/11.1.93","volume":"11","author":"W Rossoll","year":"2002","unstructured":"Rossoll, W.  et al. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp\/hnRNP-Q: a role for Smn in RNA processing in motor axons? Hum. Mol. Genet. 11, 93\u2013105 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR69","first-page":"289","volume":"48","author":"W Rossoll","year":"2009","unstructured":"Rossoll, W. & Bassell, G. J. Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes. Results Probl. Cell Differ. 48, 289\u2013326 (2009).","journal-title":"Results Probl. Cell Differ."},{"key":"BFnrneurol201577_CR70","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/hmg\/ddq500","volume":"20","author":"L Hubers","year":"2011","unstructured":"Hubers, L.  et al. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects. Hum. Mol. Genet. 20, 553\u2013579 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR71","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","volume":"32","author":"TL Martinez","year":"2012","unstructured":"Martinez, T. L.  et al. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J. Neurosci. 32, 8703\u20138715 (2012).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201577_CR72","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2174\/15665240113139990044","volume":"13","author":"BB Goulet","year":"2013","unstructured":"Goulet, B. B., Kothary, R. & Parks, R. J. At the \u201cjunction\u201d of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Curr. Mol. Med. 13, 1160\u20131174 (2013).","journal-title":"Curr. Mol. Med."},{"key":"BFnrneurol201577_CR73","doi-asserted-by":"publisher","first-page":"e93329","DOI":"10.1371\/journal.pone.0093329","volume":"9","author":"S Fayzullina","year":"2014","unstructured":"Fayzullina, S. & Martin, L. J. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of spinal muscular atrophy (SMA). PLoS ONE 9, e93329 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201577_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2044-5040-3-24","volume":"3","author":"JG Boyer","year":"2013","unstructured":"Boyer, J. G.  et al. Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy. Skelet. Muscle 3, 24 (2013).","journal-title":"Skelet. Muscle"},{"key":"BFnrneurol201577_CR75","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/hmg\/ddt612","volume":"23","author":"G Hunter","year":"2014","unstructured":"Hunter, G., Aghamaleky Sarvestany, A., Roche, S. L., Symes, R. C. & Gillingwater, T. H. SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 23, 2235\u20132250 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR76","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2012.09.011","volume":"151","author":"WL Imlach","year":"2012","unstructured":"Imlach, W. L.  et al. SMN is required for sensory-motor circuit function in Drosophila. Cell 151, 427\u2013439 (2012).","journal-title":"Cell"},{"key":"BFnrneurol201577_CR77","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","volume":"85","author":"TW Prior","year":"2009","unstructured":"Prior, T. W.  et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am. J. Hum. Genet. 85, 408\u2013413 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201577_CR78","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","volume":"14","author":"J Jarecki","year":"2005","unstructured":"Jarecki, J.  et al. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum. Mol. Genet. 14, 2003\u20132018 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/adt.2014.587","volume":"12","author":"JJ Cherry","year":"2014","unstructured":"Cherry, J. J.  et al. Assays for the identification and prioritization of drug candidates for spinal muscular atrophy. Assay Drug Dev. Technol. 12, 315\u2013341 (2014).","journal-title":"Assay Drug Dev. Technol."},{"key":"BFnrneurol201577_CR80","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.4155\/fmc.12.131","volume":"4","author":"MA Lorson","year":"2012","unstructured":"Lorson, M. A. & Lorson, C. L. SMN-inducing compounds for the treatment of spinal muscular atrophy. Future Med. Chem. 4, 2067\u20132084 (2012).","journal-title":"Future Med. Chem."},{"key":"BFnrneurol201577_CR81","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/jm061475p","volume":"51","author":"J Thurmond","year":"2008","unstructured":"Thurmond, J.  et al. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. J. Med. Chem. 51, 449\u2013469 (2008).","journal-title":"J. Med. Chem."},{"key":"BFnrneurol201577_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ana.21241","volume":"63","author":"C-Y Yuo","year":"2008","unstructured":"Yuo, C.-Y., Lin, H.-H., Chang, Y.-S., Yang, W.-K. & Chang, J.-G. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Ann. Neurol. 63, 26\u201334 (2008).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201577_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1741-7015-10-24","volume":"10","author":"M Bowerman","year":"2012","unstructured":"Bowerman, M., Murray, L. M., Boyer, J. G., Anderson, C. L. & Kothary, R. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC Med. 10, 24 (2012).","journal-title":"BMC Med."},{"key":"BFnrneurol201577_CR84","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/hmg\/ddq021","volume":"19","author":"M Bowerman","year":"2010","unstructured":"Bowerman, M., Beauvais, A., Anderson, C. L. & Kothary, R. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet. 19, 1468\u20131478 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR85","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","volume":"191","author":"RG Miller","year":"2001","unstructured":"Miller, R. G.  et al. A placebo-controlled trial of gabapentin in spinal muscular atrophy. J. Neurol. Sci. 191, 127\u2013131 (2001).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201577_CR86","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.gde.2013.03.003","volume":"23","author":"B Wirth","year":"2013","unstructured":"Wirth, B., Garbes, L. & Riessland, M. How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. Curr. Opin. Genet. Dev. 23, 330\u2013338 (2013).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnrneurol201577_CR87","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.20473","volume":"57","author":"KJ Swoboda","year":"2005","unstructured":"Swoboda, K. J.  et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann. Neurol. 57, 704\u2013712 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201577_CR88","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini, M. A.  et al. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J. Clin. Invest. 120, 1253\u20131264 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201577_CR89","doi-asserted-by":"publisher","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","volume":"2","author":"CF Valori","year":"2010","unstructured":"Valori, C. F.  et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci. Transl. Med. 2, 35ra42 (2010).","journal-title":"Sci. Transl. Med."},{"key":"BFnrneurol201577_CR90","doi-asserted-by":"publisher","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","volume":"8","author":"C Mitrpant","year":"2013","unstructured":"Mitrpant, C.  et al. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS ONE 8, e62114 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201577_CR91","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.24332","volume":"77","author":"SI Duque","year":"2014","unstructured":"Duque, S. I.  et al. A large animal model of spinal muscular atrophy and correction of phenotype. Ann. Neurol. 77, 399\u2013414 (2014).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201577_CR92","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J. & Jude Samulski, R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 20, 450\u2013459 (2013).","journal-title":"Gene Ther."},{"key":"BFnrneurol201577_CR93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D.  et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol201577_CR94","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"AK Bevan","year":"2011","unstructured":"Bevan, A. K.  et al. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol. Ther. 19, 1971\u20131980 (2011).","journal-title":"Mol. Ther."},{"key":"BFnrneurol201577_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2014","unstructured":"Meyer, K.  et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol. Ther. 23, 477\u2013487 (2014).","journal-title":"Mol. Ther."},{"key":"BFnrneurol201577_CR96","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/mt.2011.287","volume":"20","author":"A Asokan","year":"2012","unstructured":"Asokan, A., Schaffer, D. V. & Jude Samulski, R. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20, 699\u2013708 (2012).","journal-title":"Mol. Ther."},{"key":"BFnrneurol201577_CR97","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh, N. K., Singh, N. N., Androphy, E. J. & Singh, R. N. Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol. Cell. Biol. 26, 1333\u20131346 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneurol201577_CR98","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1523\/JNEUROSCI.0950-09.2009","volume":"29","author":"JH Williams","year":"2009","unstructured":"Williams, J. H.  et al. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J. Neurosci. 29, 7633\u20137638 (2009).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201577_CR99","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini, M. A.  et al. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci. Transl. Med. 3, 72ra18 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnrneurol201577_CR100","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1101\/gad.1941310","volume":"24","author":"Y Hua","year":"2010","unstructured":"Hua, Y.  et al. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev. 24, 1634\u20131644 (2010).","journal-title":"Genes Dev."},{"key":"BFnrneurol201577_CR101","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1038\/mtna.2014.23","volume":"3","author":"JM Keil","year":"2014","unstructured":"Keil, J. M.  et al. A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy. Mol. Ther. Nucleic Acids 3, e174 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol201577_CR102","doi-asserted-by":"publisher","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","volume":"8","author":"C Mitrpant","year":"2013","unstructured":"Mitrpant, C.  et al. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS ONE 8, e62114 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201577_CR103","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua, Y.  et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478, 123\u2013126 (2011).","journal-title":"Nature"},{"key":"BFnrneurol201577_CR104","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/hum.2012.211","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou, H.  et al. A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Hum. Gene Ther. 24, 331\u2013342 (2013).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol201577_CR105","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1093\/hmg\/ddu198","volume":"23","author":"EY Osman","year":"2014","unstructured":"Osman, E. Y.  et al. Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models. Hum. Mol. Genet. 23, 4832\u20134845 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201577_CR106","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/jpet.113.212407","volume":"350","author":"F Rigo","year":"2014","unstructured":"Rigo, F.  et al. Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. J. Pharmacol. Exp. Ther. 350, 46\u201355 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrneurol201577_CR107","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clinthera.2014.02.004","volume":"36","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo, M.  et al. Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy \u03947 mouse model phenotype. Clin. Ther. 36, 340\u2013356.e5 (2014).","journal-title":"Clin. Ther."},{"key":"BFnrneurol201577_CR108","volume-title":"Probe Reports from the NIH Molecular Libraries Program","author":"S Titus","year":"2010","unstructured":"Titus, S.  et al. High throughput screening for SMA. Probe Reports from the NIH Molecular Libraries Program \n                    [online]\n                    \n                  , (2010)."},{"key":"BFnrneurol201577_CR109","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nchembio.595","volume":"7","author":"NR Makhortova","year":"2011","unstructured":"Makhortova, N. R.  et al. A screen for regulators of survival of motor neuron protein levels. Nat. Chem. Biol. 7, 544\u2013552 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrneurol201577_CR110","doi-asserted-by":"publisher","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","volume":"1","author":"ML Hastings","year":"2009","unstructured":"Hastings, M. L.  et al. Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy. Sci. Transl. Med. 1, 5ra12 (2009).","journal-title":"Sci. Transl. Med."},{"key":"BFnrneurol201577_CR111","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","volume":"345","author":"NA Naryshkin","year":"2014","unstructured":"Naryshkin, N. A.  et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science 345, 688\u2013693 (2014).","journal-title":"Science"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.77","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:17:47Z","timestamp":1684455467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnrneurol201577"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.77","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]},"assertion":[{"value":"19 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}